You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

extensive-stage disease small cell lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Cancer, Lung Cancer Trial in Switzerland (Durvalumab, carboplatin, etoposide)

Recruiting
  • Small Cell Lung Cancer
  • Lung Cancer
  • Aarau, Switzerland
  • +13 more
Aug 12, 2022

Small Cell Lung Cancer Extensive Stage Trial (Sintilimab, Anlotinib HCl)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • (no location specified)
Jul 26, 2021

Small Cell Lung Cancer Extensive Stage Trial in France, Luxembourg (Carboplatin + Paclitaxel + Durvalumab)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Carboplatin + Paclitaxel + Durvalumab
  • Abbeville, France
  • +27 more
May 4, 2023

Small Cell Lung Carcinoma Trial in Zhengzhou (Camrelizumab Plus Apatinib)

Recruiting
  • Small Cell Lung Carcinoma
  • Camrelizumab Plus Apatinib
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Nov 24, 2021

Small Cell Lung Carcinoma Extensive Disease Trial in China (Durvalumab plus chemo)

Active, not recruiting
  • Small Cell Lung Carcinoma Extensive Disease
  • Durvalumab plus chemotherapy
  • Baoding, China
  • +29 more
Nov 8, 2022

Extensive Stage Small Cell Lung Cancer Trial (hSTC810 400 mg + Paclitaxel, hSTC810 800 mg + Paclitaxel)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer
  • hSTC810 400 mg + Paclitaxel
  • hSTC810 800 mg + Paclitaxel
  • (no location specified)
Aug 24, 2023

Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer (ES-SCLC)
  • (no location specified)
Sep 19, 2023

Extensive Stage Small Cell Lung Cancer

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
    • Changsha, Hunan, China
      Hunan Cancer hospital
    Aug 6, 2023

    Molecular Subtyping of Extensive Stage Small Cell Lung Cancer

    Recruiting
    • SCLC,Extensive Stage
    • PD-(L)1 antibody immunotherapy
    • Beijing, Beijing, China
      Peking University Cancer Hospital & Institute
    Jul 3, 2023

    Small Cell Lung Cancer Extensive Stage, Thoracic Radiotherapy Trial in Linz, Heidelberg (Atezolizumab, thoracic radiotherapy

    Recruiting
    • Small Cell Lung Cancer Extensive Stage
    • Thoracic Radiotherapy
    • Linz, Austria
    • +1 more
    Aug 25, 2021

    Small Cell Lung Carcinoma Extensive Disease Trial in Spain (Durvalumab, Cisplatin, Etoposide)

    Active, not recruiting
    • Small Cell Lung Carcinoma Extensive Disease
    • A Coruna, Spain
    • +33 more
    Jun 22, 2022

    Small Cell Lung Cancer Trial in Cleveland (Alisertib)

    Not yet recruiting
    • Small Cell Lung Cancer
    • Cleveland, Ohio
      Cleveland Clinic
    Oct 18, 2023

    Extensive-stage Small-cell Lung Cancer Trial in Sydney, Brisbane, Melbourne (Radiotherapy, Chemotherapy)

    Recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Sydney, New South Wales, Australia
    • +6 more
    Mar 21, 2023

    Durvalumab in Combination With Standard Chemotherapy of

    Recruiting
    • Small-cell Lung Cancer
    • Extensive-stage Small-cell Lung Cancer
      • Néo Fáliro, Greece
        Metropolitan Hospital
      Mar 7, 2023

      Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer Trial (Durvalumab, Monalizumab, Carboplatin or Cisplatin)

      Not yet recruiting
      • Small Cell Lung Cancer
      • +2 more
      • (no location specified)
      Jun 5, 2023

      Small Cell Lung Cancer Trial in Changchun (BL-B01D1, SI-B003)

      Not yet recruiting
      • Small Cell Lung Cancer
      • Changchun, Jilin, China
        Jilin Cancer Hospital
      Jun 21, 2023

      Extensive Stage Small Cell Lung Cancer Trial in Hangzhou (Tislelizumab, Anlotinib)

      Recruiting
      • Extensive Stage Small Cell Lung Cancer
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Jun 6, 2023

      Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

      Not yet recruiting
      • Extensive-stage Small-cell Lung Cancer
      • (no location specified)
      May 22, 2023

      Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

      Not yet recruiting
      • Small Cell Lung Cancer Extensive Stage
      • Jinan, China
      • +2 more
      Sep 10, 2023

      Small Cell Lung Cancer Trial in Fuzhou (Surufatinib,Serplulimab,Etoposide,Carboplatin)

      Not yet recruiting
      • Small Cell Lung Cancer
      • Fuzhou, Fujian, China
        Fujian Cancer Hospital
      May 20, 2023

      Small Cell Lung Cancer Extensive Stage Trial (quaratusugene ozeplasmid, atezolizumab)

      Not yet recruiting
      • Small Cell Lung Cancer Extensive Stage
      • quaratusugene ozeplasmid
      • atezolizumab
      • (no location specified)
      Jan 19, 2023

      Outcomes ofBrazilian Cohort of Previously Untreated Extensive

      Not yet recruiting
      • Extensive-stage Small-cell Lung Cancer
      • Observational study
      • (no location specified)
      Aug 24, 2023

      Recurrent Extensive Stage Small Cell Lung Carcinoma, Refractory Extensive Stage Small Cell Lung Carcinoma Trial in United States

      Active, not recruiting
      • Recurrent Extensive Stage Small Cell Lung Carcinoma
      • Refractory Extensive Stage Small Cell Lung Carcinoma
      • Bakersfield, California
      • +5 more
      Jan 5, 2023

      Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

      Active, not recruiting
      • Acute Myeloid Leukemia
      • +66 more
      • Best Practice
      • +3 more
      • Fullerton, California
        Virginia K Crosson Cancer Center
      Jan 31, 2022

      Small Cell Lung Cancer Extensive Stage, Large Cell Neuroendocrine Carcinoma of the Lung Trial (LB2102)

      Not yet recruiting
      • Small Cell Lung Cancer Extensive Stage
      • Large Cell Neuroendocrine Carcinoma of the Lung
      • LB2102
      • (no location specified)
      Jan 10, 2023